T1	Organism 27 32	Human
T2	OrganismPart 33 38	Heart
T3	Disease 107 154	Dilated Left Atrium Without Atrial Fibrillation
T4	Disease 432 453	mitral valve prolapse
T5	Disease 455 458	MVP
*	Equiv T4 T5
T6	OrganismPart 713 724	right atria
T7	OrganismPart 726 728	RA
T8	OrganismPart 731 741	left atria
T9	OrganismPart 743 745	LA
T10	OrganismPart 751 765	left ventricle
T11	OrganismPart 767 769	LV
*	Equiv T6 T7
*	Equiv T8 T9
*	Equiv T10 T11
T12	NumberOfSamples 774 779	seven
T13	Sex 780 784	male
T14	Disease 831 862	dilated LA but no history of AF
T15	Instrument 1055 1077	Q-Exactive-HF Orbitrap
T16	FractionationMethod 976 1025	reverse phase high-pressure liquid chromatography
T17	SupplementaryFile 5897 5920	Supplementary Materials
T18	NumberOfBiologicalReplicates 5990 5995	seven
T19	OrganismPart 6065 6067	LA
T20	OrganismPart 6069 6071	RA
T21	OrganismPart 6073 6075	LV
T22	NumberOfSamples 6087 6089	21
T23	NumberOfFractions 6116 6118	12
T24	NumberOfTechnicalReplicates 6196 6198	No
T25	NumberOfBiologicalReplicates 6522 6527	three
T26	ReductionReagent 8466 8495	Tris(2-carboxyethyl)phosphine
T27	AlkylationReagent 8513 8528	chloroacetamide
T28	ReductionReagent 8497 8501	TCEP
*	Equiv T26 T28
T29	AlkylationReagent 8530 8533	CAA
*	Equiv T27 T29
T30	FactorValue 6065 6067	LA
T31	FactorValue 6069 6071	RA
T32	FactorValue 6073 6075	LV
T33	CleavageAgent 8668 8673	Lys-C
T34	CleavageAgent 8843 8850	trypsin
T35	FractionationFraction 8988 8995	Soluble
T36	FractionationMethod 9206 9270	micro-flow reverse-phase ultrahigh pressure liquid chromatograpy
T37	FractionationMethod 9272 9276	UPLC
*	Equiv T36 T37
T38	Separation 9637 9680	online reversed-phase liquid chromatography
T39	Instrument 9694 9727	Q-Exactive HF quadrupole Orbitrap
T40	IonizationType 10479 10507	nano-electrospray ionization
T41	AcquisitionMethod 10751 10765	data-dependent
T42	FragmentationMethod 10867 10905	higher-energy collisional dissociation
T43	FragmentationMethod 10907 10910	HCD
*	Equiv T42 T43
T44	Label 11397 11407	label-free
T45	Label 11424 11427	LFQ
*	Equiv T44 T45
